These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11023757)

  • 1. Chemoprophylaxis is effective in the prevention of leprosy in endemic countries: a systematic review and meta-analysis. MILEP2 Study Group. Mucosal Immunology of Leprosy.
    Smith CM; Smith WC
    J Infect; 2000 Sep; 41(2):137-42. PubMed ID: 11023757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trials of preventive therapy.
    Blanc LJ
    Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4 Suppl):S7-9. PubMed ID: 10700928
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of leprosy using rifampicin as chemoprophylaxis.
    Bakker MI; Hatta M; Kwenang A; Van Benthem BH; Van Beers SM; Klatser PR; Oskam L
    Am J Trop Med Hyg; 2005 Apr; 72(4):443-8. PubMed ID: 15827283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of rifampicin chemoprophylaxis in preventing leprosy in patient contacts: a systematic review of quantitative and qualitative evidence.
    Ferreira SMB; Yonekura T; Ignotti E; Oliveira LB; Takahashi J; Soares CB
    JBI Database System Rev Implement Rep; 2017 Oct; 15(10):2555-2584. PubMed ID: 29035966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of a chemoprophylactic intervention with single dose rifampicin in contacts of new leprosy patients.
    Idema WJ; Majer IM; Pahan D; Oskam L; Polinder S; Richardus JH
    PLoS Negl Trop Dis; 2010 Nov; 4(11):e874. PubMed ID: 21072235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting the impact of household contact and mass chemoprophylaxis on future new leprosy cases in South Tarawa, Kiribati: A modelling study.
    Gilkison C; Chambers S; Blok DJ; Richardus JH; Timeon E; Rimon E; Priest P
    PLoS Negl Trop Dis; 2019 Sep; 13(9):e0007646. PubMed ID: 31539374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoprophylaxis in contacts of patients with leprosy: systematic review and meta-analysis.
    Reveiz L; Buendía JA; Téllez D
    Rev Panam Salud Publica; 2009 Oct; 26(4):341-9. PubMed ID: 20107683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceptability of chemoprophylaxis for household contacts of leprosy patients in Bangladesh: a qualitative study.
    Feenstra SG; Nahar Q; Pahan D; Oskam L; Richardus JH
    Lepr Rev; 2011 Jun; 82(2):178-87. PubMed ID: 21888142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Report of the workshop on the use of chemoprophylaxis in the control of leprosy held in Amsterdam, The Netherlands on 14 December 2006.
    Oskam L; Mi B
    Lepr Rev; 2007 Jun; 78(2):173-85. PubMed ID: 17824494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited duration acedapsone prophylaxis in leprosy.
    Neelan PN; Sirumban P; Sivaprasad N
    Indian J Lepr; 1986; 58(2):251-6. PubMed ID: 3543161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoprophylaxis against leprosy with acedapsone. An interim report.
    Noordeen SK; Neelan PN; Munaf A
    Lepr India; 1980 Jan; 52(1):97-103. PubMed ID: 6991817
    [No Abstract]   [Full Text] [Related]  

  • 12. The State of Affairs in Post-Exposure Leprosy Prevention: A Descriptive Meta-Analysis on Immuno- and Chemo-Prophylaxis.
    Schoenmakers A; Mieras L; Budiawan T; van Brakel WH
    Res Rep Trop Med; 2020; 11():97-117. PubMed ID: 33117053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of contact tracing and prevention strategies in the interruption of leprosy transmission.
    Smith WC; Aerts A
    Lepr Rev; 2014 Mar; 85(1):2-17. PubMed ID: 24974438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protocol, rationale and design of PEOPLE (Post ExpOsure Prophylaxis for LEprosy in the Comoros and Madagascar): a cluster randomized trial on effectiveness of different modalities of implementation of post-exposure prophylaxis of leprosy contacts.
    Ortuno-Gutierrez N; Younoussa A; Randrianantoandro A; Braet S; Cauchoix B; Ramboarina S; Baco A; Mzembaba A; Salim Z; Amidy M; Grillone S; Richardus JH; de Jong BC; Hasker E
    BMC Infect Dis; 2019 Dec; 19(1):1033. PubMed ID: 31805862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoprophylaxis against leprosy: expectations and methodology of a trial.
    Vijayakumaran P; Krishnamurthy P; Rao P; Declerq E
    Lepr Rev; 2000 Dec; 71 Suppl():S37-40; discussion S40-1. PubMed ID: 11201885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of the combination BCG vaccination and rifampicin prophylaxis in leprosy prevention.
    Schuring RP; Richardus JH; Pahan D; Oskam L
    Vaccine; 2009 Nov; 27(50):7125-8. PubMed ID: 19786134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protecting people against leprosy: chemoprophylaxis and immunoprophylaxis.
    Richardus JH; Oskam L
    Clin Dermatol; 2015; 33(1):19-25. PubMed ID: 25432807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoprophylaxis in the prevention of leprosy.
    Smith WC
    BMJ; 2008 Apr; 336(7647):730-1. PubMed ID: 18390497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoprophylaxis of leprosy in the southern Marquesas with a single 25 mg/kg dose of rifampicin. Results after 10 years.
    Nguyen LN; Cartel JL; Grosset JH
    Lepr Rev; 2000 Dec; 71 Suppl():S33-5; discussion S35-6. PubMed ID: 11201884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoprophylaxis against leprosy with acedapsone.
    Neelan PN; Noordeen SK; Sivaprasad N
    Indian J Med Res; 1983 Sep; 78():307-13. PubMed ID: 6674153
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.